ArticleOncotarget2017

Shikonin protects against D-Galactosamine and lipopolysaccharide-induced acute hepatic injury by inhibiting TLR4 signaling pathway.

Meng-Xiang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.